Diabetic Retinopathy (c) AAO The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. More than 6 million people in the U.S. use either semaglutide or tirzepatide—drugs that reduce blood sugar, slow gastric emptying and reduce appetite. GLP-1 agonists like semaglutide lower blood sugar by mimicking the body’s natural hormone...

In the conventional laser group, PRP was completed using the LightMed LightLas 532 laser device in accordance with the ETDRS protocol

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have created a novel protocol to rapidly diagnose eye stroke and...